Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04092634 · ClinicalTrials.gov registry record · Phase 4
Dual Mobility in "High Risk" Patients
A Phase 4 study of Dislocation, Hip, sponsored by Rush University Medical Center.
- Active
- Registry status
- Phase 4
- Development phase
- 412
- Enrollment target
- 4
- Study locations
NCT04092634 is a Phase 4 study of Dislocation, Hip that is active but no longer recruiting, run by Rush University Medical Center. The registered enrollment target is 412 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT04092634, a Phase 4 study of Dislocation, Hip, is active but no longer recruiting, sponsored by Rush University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 412 participants
- Enrollment target
- 4
- Study locations
Study Summary
The aim of this study is to compare clinical outcomes of patients considered to be high risk for prosthetic dislocation undergoing primary total hip arthroplasty (THA) with the use of a dual mobility bearing versus a conventional, single bearing design.
Conditions Studied
Interventions
- DEVICE Dual mobility implant
- DEVICE Traditional, Single-bearing hip implant
Study Locations (4)
California
- Keck School of Medicine of USC - Los Angeles
Illinois
- Rush University Medical Center - Chicago
New York
- New York University Medical Center - New York
Pennsylvania
- Rothman Orthopaedic Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2035-02-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04092634
The ClinicalTrials.gov registry entry for NCT04092634 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 412 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dislocation, Hip appearing as the primary indexed condition, and to 2 interventions - of which Dual mobility implant is the first listed.
NCT04092634 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT04092634 about?
NCT04092634 is a clinical study titled "Dual Mobility in "High Risk" Patients". The aim of this study is to compare clinical outcomes of patients considered to be high risk for prosthetic dislocation undergoing primary total hip arthroplasty (THA) with the use of a dual mobility bearing versus a conventional, single bearing design.
What is the current status of trial NCT04092634?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 412 participants. The study started on 2017-11-01. Estimated completion is 2035-02-01.
What conditions does trial NCT04092634 study?
This clinical trial studies the following conditions: Dislocation, Hip.
What interventions are being tested in trial NCT04092634?
The interventions under investigation include: Dual mobility implant (DEVICE), Traditional, Single-bearing hip implant (DEVICE).
Who is sponsoring clinical trial NCT04092634?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04092634 being conducted?
This trial has 4 study locations across California, Illinois, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dislocation, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.